Author: TradingView
Delivered 6,520 vehicles in FY25 with $519M revenue and a 9% gross margin, while narrowing net loss by 58% year-over-year. Lifestyle vehicles led deliveries, and new hybrid models and strategic partnerships are set to drive future growth.Original document: Lotus Technology Slides Release — Apr. 10…Read More
A travel writer who lives in Italy shares the 15 American preppy clothing styles she’s spotting in Italy right now. Shop knit sweaters, pleated skirts, khaki pants, and Western-style boots, starting at $27.Read More
Pope Leo XIV’s Apostolic to four African nations will be visible for the first time live on the Vatican News widget, which offers Catholic websites …Read More
The project pairs RLUSD settlement with tax collection and reporting for Ghana MSMEs. Pilot rollouts across African markets are targeted for mid-2026.Read More
The Professional Fighters League today announced the first pair of bouts as PFL Africa heads to Nigeria forRead More
These results reflect the accelerating transition towards an advanced cash-light economy, with the platform now serving as a key pillar for daily transfers and financial transactions for individuals and businesses across the UAE.Read More
The session concluded with a call to move beyond traditional financing approaches by reducing the cost of capital, expanding risk-sharing and co-financing mechanisms, strengthening project preparation and investment pipelines, mobilizing long-term funding at scale, and enhancing collaboration among African institutions and development partners.Read More
To start with Middle EastRead More
Sensors on Aqua, Suomi-NPP, and NOAA-20 detected fires and poor air quality across Thailand, Laos, Cambodia, Vietnam, and other countries in early April 2026.Read More
Erasca recently reported encouraging clinical progress for its lead pan-RAS candidate ERAS-0015, including partial responses in patients and no dose-limiting toxicities, while also expanding its licensing agreement with Joyo Pharmatech to cover China, Hong Kong, and Macau. The expanded Joyo Pharmatech agreement gives Erasca global control over development and future data releases, potentially tightening coordination between clinical results and future commercial planning. Next, we’ll examine…Read More